iScience (Jan 2023)

Peripheral B cells from patients with hepatitis C virus-associated lymphoma exhibit clonal expansion and an anergic-like transcriptional profile

  • Amanda N. Henning,
  • Myagmarjav Budeebazar,
  • Delgerbat Boldbaatar,
  • Dahgwahdorj Yagaanbuyant,
  • Davaadorj Duger,
  • Khishigjargal Batsukh,
  • Huizhi Zhou,
  • Ryan Baumann,
  • Robert D. Allison,
  • Harvey J. Alter,
  • Naranjargal Dashdorj,
  • Valeria De Giorgi

Journal volume & issue
Vol. 26, no. 1
p. 105801

Abstract

Read online

Summary: Chronic HCV infection remains a global health concern due to its involvement in hepatic and extrahepatic diseases, including B cell non-Hodgkin lymphoma (BNHL). Clinical and epidemiological evidence support a causal role for HCV in BNHL development, although mechanistic insight is lacking. We performed RNA-sequencing on peripheral B cells from patients with HCV alone, BNHL alone, and HCV-associated BNHL to identify unique and shared transcriptional profiles associated with transformation. In patients with HCV-associated BNHL, we observed the enrichment of an anergic-like gene signature and evidence of clonal expansion that was correlated with the expression of epigenetic regulatory genes. Our data support a role for viral-mediated clonal expansion of anergic-like B cells in HCV-associated BNHL development and suggest epigenetic dysregulation as a potential mechanism driving expansion. We propose epigenetic mechanisms may be involved in both HCV-associated lymphoma and regulation of B cell anergy, representing an attractive target for clinical interventions.

Keywords